IMPL Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 6.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $55,148.21

Impel Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Impel Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Impel Pharmaceuticals Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 12/21/2023 12:59 AM ET

This chart shows the closing price history over time for IMPL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Impel Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/18/2023Vivo Capital Viii, LlcMajor ShareholderSell237,711$0.11$26,148.21308,926View SEC Filing Icon  
12/15/2023Vivo Capital Viii, LlcMajor ShareholderSell100,000$0.29$29,000.00337,608View SEC Filing Icon  
11/19/2021Timothy S. NelsonDirectorBuy10,000$10.76$107,600.00View SEC Filing Icon  
8/18/2021Adrian AdamsCEOBuy20,000$13.99$279,800.0017,203View SEC Filing Icon  
4/27/2021Vivo Capital Viii, LlcMajor ShareholderBuy575,000$15.00$8,625,000.0098,927View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Impel Pharmaceuticals (NASDAQ:IMPL)

73.88% of Impel Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMPL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Impel Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Lasry Marc225,874$97K0.1%-44.7%0.951%Search for SEC Filing on Google Icon
8/9/2023DCF Advisers LLC303,605$0.39M0.2%-20.8%1.278%Search for SEC Filing on Google Icon
7/17/2023Mcdonald Partners LLC20,200$26K0.0%+72.6%0.085%Search for SEC Filing on Google Icon
1/18/2023Mcdonald Partners LLC11,700$44K0.0%N/A0.049%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC24,447$0.12M0.0%-13.9%0.103%Search for SEC Filing on Google Icon
8/15/2022Opaleye Management Inc.144,642$1.35M0.6%N/A0.624%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP124,800$1.16M0.0%N/A0.539%Search for SEC Filing on Google Icon
8/11/2022DCF Advisers LLC438,566$4.09M2.4%+19.5%1.893%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd11,867$76K0.0%-41.7%0.051%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd5,864$51K0.0%N/A0.025%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.208,760$1.80M0.0%N/A0.906%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd20,342$0.18M0.0%N/A0.088%Search for SEC Filing on Google Icon
2/9/2022Alps Advisors Inc.26,662$0.23M0.0%N/A0.116%Search for SEC Filing on Google Icon
2/3/2022Brighton Jones LLC14,145$0.12M0.0%N/A0.061%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd20,342$0.18M0.0%N/A0.088%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC26,675$0.23M0.0%N/A0.116%Search for SEC Filing on Google Icon
1/25/2022Epiq Partners LLC18,646$0.16M0.1%N/A0.081%Search for SEC Filing on Google Icon
12/10/2021Towercrest Capital Management50,500$0.62M0.1%N/A0.219%Search for SEC Filing on Google Icon
11/15/2021First Manhattan Co.6,700$81K0.0%N/A0.034%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC117,916$1.44M0.0%+131.5%0.604%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.268,730$3.27M0.0%+7.0%1.377%Search for SEC Filing on Google Icon
11/8/2021Trustcore Financial Services LLC13,407$0.16M0.0%N/A0.069%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.200,806$2.45M0.0%N/A1.029%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund6,867$84K0.0%-49.9%0.035%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.80,390$0.98M0.0%-28.7%0.412%Search for SEC Filing on Google Icon
10/13/2021FNY Investment Advisers LLC5,377$65K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP119,615$1.06M0.0%N/A0.537%Search for SEC Filing on Google Icon
8/17/2021Zimmer Partners LP25,000$0.22M0.0%N/A0.112%Search for SEC Filing on Google Icon
8/17/2021Kohlberg Kravis Roberts & Co. L.P.3,802,639$33.65M0.1%N/A17.071%Search for SEC Filing on Google Icon
8/16/20215AM Venture Management LLC2,884,791$25.53M6.4%N/A12.950%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System7,464$66K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/16/2021venBio Partners LLC2,759,791$24.42M2.9%N/A12.389%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP6,188$55K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.11,413$0.10M0.0%N/A0.051%Search for SEC Filing on Google Icon
8/16/2021State Street Corp46,298$0.41M0.0%N/A0.208%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp58,493$0.52M0.0%N/A0.263%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC50,942$0.45M0.0%N/A0.229%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.183,753$1.63M0.0%N/A0.825%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.6,653$59K0.0%N/A0.030%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.251,063$2.22M0.0%N/A1.127%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG3,196$28K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/10/2021Norwest Venture Partners Xiv LP3,077,198$27.23M31.4%N/A13.814%Search for SEC Filing on Google Icon
8/3/2021Victory Capital Management Inc.112,730$1M0.0%N/A0.506%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Impel Pharmaceuticals logo
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. The company was incorporated in 2008 and is headquartered in Seattle, Washington.
Read More on Impel Pharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: $0.27
Low: $0.04
High: $0.84

52 Week Range

Now: N/A

Volume

720,000 shs

Average Volume

682,655 shs

Market Capitalization

$956,000.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Who are the company insiders with the largest holdings of Impel Pharmaceuticals?

Impel Pharmaceuticals' top insider shareholders include:
  1. Vivo Capital Viii, Llc (Major Shareholder)
Learn More about top insider investors at Impel Pharmaceuticals.